Resistance, Treatment and Prevention of ESKAPE Pathogens
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Mechanism and Evolution of Antibiotic Resistance".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 21
Special Issue Editors
2. Department of Chemistry, Furman University, Greenville, SC 29613, USA
3. Department of Pathology, Prisma Health, Greenville, SC 29605, USA
4. Family Medicine Residency at Lee Health, Florida State University College of Medicine, Fort Myers, FL 33901, USA
5. Internal Medicine Residency at Lee Health, Florida State University College of Medicine, Cape Coral, FL 33990, USA
6. School of Health Science Research, Clemson University, Clemson, SC 29634, USA
Interests: Acinetobacter; Klebsiella; drug discovery; antimicrobial stewardship; virulence factors; infectious diseases; bacteriology
Special Issues, Collections and Topics in MDPI journals
Interests: Acinetobacter; Stenotrophomonas; drug discovery; virulence factors; infectious diseases; bacterial iron-acquisition
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We would like to invite you to submit your research pertaining to the resistance and/or treatment of ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) for publication consideration in this Special Issue of Antibiotics. Infections caused by ESKAPE pathogens are a substantial burden on public health with the Centers for Disease Control and Prevention, specifically classifying carbapenem-resistant Acinetobacter as well as carbapenem-resistant Enterobacteriaceae as urgent threats to public health with a combined 21,600 cases, 1800 deaths, and USD 411 million in associated healthcare costs reported annually in the United States alone. These data coupled with the sparsity of information elucidating the pathophysiology of ESKAPE pathogens such as Acinetobacter, the lack of novel antibiotics in the developmental pipeline and the continued occurrence of multidrug, extensive drug-, or even pandrug-resistant isolates from clinical settings constitute public health crises warranting immediate attention. This Special Issue therefore particularly encourages submissions that describe resistance mechanisms of ESKAPE pathogens that allow these pathogens to resist destruction by the immune system, persist in the clinical environment due to resistance to disinfectants and survive clinical treatment due to antibiotic resistance. The underlying resistance mechanisms utilized by ESKAPE pathogens to survive these stressors all play a role in their pathogenicity and are valuable in understanding and treating this critical pathogen.
Dr. Steven E. Fiester
Dr. William Penwell
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotic resistance
- prevention methods
- treatment strategies
- ESKAPE pathogens
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
